Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ATNM
#4483
Actinium Pharmaceuticals, Inc
1.110
0
USD
+1.83%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.83%
Monthly Change
-1.77%
6 month change
+6.73%
Year Change
+6.73%
Previous Close
1.090
0
Open
1.120
0
Bid
Ask
Low
1.105
0
High
1.120
0
Volume
14
Markets
US Stock Market
Healthcare
ATNM
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
19.25 M
22.14 M
25.73 M
29.4 M
31.2 M
31.37 M
—
Valuation ratios
Enterprise value
86.56 M
61.04 M
159.52 M
89.75 M
-33.6 M
-5.33 M
-40.16 M
Price to earnings ratio
—
—
-7.31
-2.91
-0.99
-1.25
-4.87
Price to sales ratio
—
—
234.85
1 747.33
—
471.4
—
Price to cash flow ratio
—
—
27.98
-2.99
-1.15
-1.73
-6.6
Price to book ratio
—
—
3.64
3.89
1.16
5.42
6.68
Enterprise value to EBITDA ratio
-3.87
-2.38
-4.71
-1.74
0.8
0.15
0.92
Profitability ratios
Return on assets %
-0.33
-0.31
-0.29
-0.6
-0.5
-0.65
-0.55
Return on equity %
-0.36
-0.34
-0.5
-1.34
-1.17
-4.33
-2.11
Return on invested capital %
-4 237.51
—
-1 838.12
—
-2 117.03
-4 762.29
—
Gross margin %
—
21.33
100
100
—
100
—
Operating margin %
—
-2 182.17
-3 311.07
-64.1 K
—
-40.27 K
—
EBITDA margin %
—
-2 244.58
-3 290.97
-63.84 K
—
-40.08 K
—
Net margin %
—
-2 165.56
-3 205.53
-60.27 K
—
-37.65 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.62
11.66
10.44
9.21
9.14
6.2
30.84
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.02
0.01
0
0
0
0
Solvency ratios
Debt to assets ratio
—
0.07
0.09
0.12
—
—
—
Debt to equity ratio
—
0.08
0.16
0.28
—
—
—
Long term debt to total assets ratio
—
0.07
0.09
0.1
—
—
—
Long term debt to total equity ratio
—
0.08
0.15
0.22
—
—
—
Per share metrics
Operating cash flow per share
—
—
0.36
-1.78
-1.1
-0.79
-0.79
EBIT per share
—
—
-1.41
-1.95
-1.4
-1.16
-1.16
EBITDA per share
—
—
-1.4
-1.94
-1.39
-1.16
-1.16
Total debt per share
—
—
0.44
0.38
—
—
—
Cash per share
—
—
4.51
2.88
2.42
1.54
7.27
Net current asset value per share
—
—
4.6
2.94
2.48
1.58
7.41
Tangible book value per share
—
—
2.75
-0.9
-1.72
-3.42
-1.55
Working capital per share
—
—
4.16
2.62
2.21
1.33
6.44
Book value per share
—
—
2.75
1.37
1.09
0.25
2.13
News
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?
Actinium Pharmaceuticals stock rises after promising breast cancer therapy data
Actinium’s breast cancer therapy shows promise in preclinical studies
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?
Actinium’s ATNM-400 shows efficacy in resistant breast cancers
Actinium Pharmaceuticals elects directors and approves proposals at annual meeting
Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?
Actinium’s ATNM-400 shows superior efficacy against lung cancer
Actinium’s ATNM-400 shows promising results in prostate cancer models
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
Actinium’s prostate cancer therapy shows promise against resistant tumors